RELAY THERAPEUTICS INC's ticker is RLAY and the CUSIP is 75943R102. A total of 140 filers reported holding RELAY THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 1.04 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $749,348 | -32.0% | 89,102 | +1.6% | 0.00% | – |
| Q2 2023 | $1,101,926 | -92.1% | 87,733 | -89.7% | 0.00% | -100.0% |
| Q1 2023 | $14,007,735 | -10.8% | 850,500 | -19.1% | 0.00% | 0.0% |
| Q4 2022 | $15,708,289 | +6.7% | 1,051,425 | +59.7% | 0.00% | 0.0% |
| Q3 2022 | $14,728,000 | -57.1% | 658,385 | -67.8% | 0.00% | -57.1% |
| Q2 2022 | $34,293,000 | -43.3% | 2,047,352 | +1.3% | 0.01% | -30.0% |
| Q1 2022 | $60,474,000 | -1.5% | 2,020,514 | +1.1% | 0.01% | 0.0% |
| Q4 2021 | $61,375,000 | +38.3% | 1,998,548 | +42.0% | 0.01% | +25.0% |
| Q3 2021 | $44,389,000 | -4.3% | 1,407,841 | +11.0% | 0.01% | 0.0% |
| Q2 2021 | $46,403,000 | +58.8% | 1,268,187 | +50.1% | 0.01% | +60.0% |
| Q1 2021 | $29,216,000 | +389.7% | 845,104 | +488.8% | 0.01% | +400.0% |
| Q4 2020 | $5,966,000 | -36.6% | 143,531 | -35.0% | 0.00% | -50.0% |
| Q3 2020 | $9,404,000 | – | 220,788 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management IV, LLC | 2,139,380 | $73,958,000 | 8.86% |
| Darwin Global Management, Ltd. | 782,471 | $27,050,000 | 5.30% |
| EcoR1 Capital, LLC | 3,429,363 | $118,553,000 | 5.26% |
| Foresite Capital Management V, LLC | 400,000 | $13,828,000 | 4.06% |
| Grace Capital | 183,112 | $6,330,000 | 4.03% |
| BVF INC/IL | 2,873,147 | $99,325,000 | 3.72% |
| Casdin Capital, LLC | 3,375,058 | $116,676,000 | 3.48% |
| Fernwood Investment Management, LLC | 185,063 | $6,398,000 | 2.35% |
| Alphabet Inc. | 1,568,486 | $54,222,000 | 2.19% |
| SB INVESTMENT ADVISERS (UK) LTD | 27,904,963 | $964,675,000 | 1.67% |